Skip to content
The Nexus
DossierENTITY

clinical trial

Coverage of clinical trial in the Nexus archive.

Earliest in view: Apr 3 · 08:55 UTCMost recent: Jul 3 · 10:47 UTC
Co-mentioned in this coverage
Recent coverage
  • HEALTHJul 3 · 10:47 UTCALLAFRICA
    Congo-Kinshasa: Ebola Outbreak Worsens

    The Democratic Republic of Congo has launched a clinical trial of experimental Ebola treatments as the outbreak continues to spread in the north-east of the country.

  • HEALTHJun 16 · 16:45 UTCSTAT NEWS
    STAT+: How a biotech turned a trial failure into an AI model

    A biotech company transformed a failed clinical trial into an AI model, as reported in STAT's Health Tech newsletter. The article discusses how this approach is being used in the life sciences technology sector.

  • HEALTHJun 4 · 13:18 UTCSCIENCE DAILY
    Scientists finally crack an “undruggable” pancreatic cancer target and nearly double survival

    Scientists have developed a drug, daraxonrasib, targeting the KRAS mutation in pancreatic cancer, which was previously considered undruggable. The drug nearly doubled survival rates for patients with advanced pancreatic cancer and reduced the risk of death by 60% in a major clinical trial.

  • HEALTHJun 1 · 20:07 UTCDAILY MAIL
    Wonder pill shrinks tumours in a third of patients with six hard-to-treat cancers, early trial shows

    An experimental 'wonder pill' reduced tumors in one-third of patients with six challenging-to-treat cancers, according to an early-stage clinical trial. The results suggest potential therapeutic promise for these aggressive cancer types.

  • HEALTHMay 31 · 15:43 UTCHACKER NEWS
    Daily pill can double survival time for deadliest cancer, trial shows

    A daily pill called Daraxonrasib was found to double survival time for pancreatic cancer patients in a clinical trial, according to a study. The treatment shows significant improvement in outcomes for the deadliest form of cancer.

  • HEALTHMay 31 · 12:00 UTCTHE GUARDIAN WORLD
    Daily pill can double survival time for world’s deadliest cancer, trial shows

    A daily pill called daraxonrasib can double survival time for patients with advanced pancreatic cancer, according to a clinical trial hailed as a 'gamechanger' by experts. Pancreatic cancer is described as the world’s deadliest cancer with few effective treatments.

  • HEALTHMay 22 · 11:07 UTCSCIENCE DAILY
    Scientists discover simple way to relieve arthritis pain without pills or surgery

    Researchers discovered that a simple walking technique involving a slight foot angle adjustment can effectively reduce knee osteoarthritis pain in a year-long clinical trial. This non-invasive method proved as effective as common medications while also slowing cartilage damage in the joint.

  • HEALTHMay 14 · 14:22 UTCSCIENCE DAILY
    Scientists say a daily multivitamin may help slow aging

    A daily multivitamin may help slow biological aging in older adults, with participants showing slower aging after two years. The effect was equivalent to about four months less biological aging. People who were biologically older than their actual age benefited the most.

  • HEALTHMay 3 · 17:23 UTCCBS NEWS
    FDA expanding access to pancreatic cancer drug to some patients

    The FDA announced it is expanding access to a pancreatic cancer drug that showed nearly doubled survival time for patients with advanced pancreatic cancer in a large clinical trial. This decision aims to provide earlier access to the promising treatment.

  • HEALTHApr 23 · 06:45 UTCSCIENCE DAILY
    Simple “gut reset” may stop weight gain after Ozempic or Wegovy

    A new minimally invasive procedure called duodenal mucosal resurfacing may help prevent weight regain after discontinuing Ozempic or Wegovy. Clinical trials showed participants who underwent the treatment regained less weight compared to others, as the procedure renews the upper small intestine lining and potentially resets metabolism.

  • HEALTHApr 20 · 22:50 UTCDAILY MAIL
    Groundbreaking bowel cancer trial follow-up shows zero relapses

    A groundbreaking bowel cancer trial follow-up reported zero relapses among participants, indicating potential long-term success. The study suggests that the treatment may prevent cancer recurrence effectively.

  • HEALTHApr 18 · 22:30 UTCNBC NEWS
    Pancreatic cancer mRNA vaccine shows lasting results in an early trial

    An mRNA vaccine for pancreatic cancer has shown lasting results in an early clinical trial, offering potential new treatment options. The trial's success highlights the vaccine's ability to target the disease effectively.

  • HEALTHApr 16 · 03:50 UTCSCIENCE DAILY
    This cheap drug could help people with type 1 diabetes use less insulin

    A clinical trial found that metformin, a low-cost drug used for type 2 diabetes, may help type 1 diabetes patients reduce insulin usage by 12% while maintaining stable blood sugar levels. The drug's mechanism was unexpected, as researchers initially aimed to address insulin resistance.

  • HEALTHApr 7 · 00:00 UTCNATURE NEWS
    This method to reverse cellular ageing is about to be tested in humans

    A clinical trial is set to begin testing a method to reverse cellular ageing in humans, aiming to rejuvenate aged tissues and organs. The study, published in Nature, explores whether dialing back cell development can be safely applied to human tissues.

  • HEALTHApr 3 · 08:55 UTCSCIENCE DAILY
    This 5-day diet helped Crohn’s patients feel better fast

    A new clinical trial shows that a five-day monthly fasting-mimicking diet can reduce symptoms and inflammation markers in Crohn’s disease patients.

clinical trial · Dossier · The Nexus